EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer’s disease combined with insilico molecular docking

Hammad Ismail iD, Dania Khalid, Durdana Waseem, Muhammad Umar Ijaz iD, Erum Dilshad, Ihsan-Ul Haq, Muhammad Zeeshan Bhatti, Sadaf Anwaar, Madiha Ahmed, Samreen Saleem

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286349 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift PLOS ONE, 2023. Verfasst von Hammad Ismail und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, University of Gujrat, Gujrat, Pakistan. Hauptthemen laut MEDLINE: Alzheimer Disease, Berberine, Berberis, Lycium. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee on Scientific and Technological Cooperation of the Organization of Islamic Conference, Islamabad, Pakistan and International Foundation for Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Berberis lycium is an indigenous plant of Pakistan that is known for its medicinal properties. In the current study, we investigated the anti-Alzheimer’s effect of berberine isolated from Berberis lycium .

Methods

Root extract of B . lycium was subjected to acetylcholinesterase inhibition assay and column chromatography for bioassays guided isolation of a compound. The neuroprotective and memory improving effects of isolated compound were evaluated by aluminium chloride induced Alzheimer’s disease rat model, elevated plus maze (EPM) and Morris water maze (MWM) tests., Levels of dopamine and serotonin in rats brains were determined using HPLC. Moreover, western blot and docking were performed to determine interaction between berberine and β-secretase.

Results

During fractionation, ethyl acetate and methanol (3:7) fraction was collected from solvent mixture of ethyl acetate and methanol. This fraction showed the highest anti-acetylcholinesterase activity and was alkaloid positive. The results of TLC and HPLC analysis indicated the presence of the isolated compound as berberine. Additionally, the confirmation of isolated compound as berberine was carried out using FTIR and NMR analysis. In vivo EPM and MWM tests showed improved memory patterns after berberine treatment in Alzheimer’s disease model. The levels of dopamine, serotonin and activity of antioxidant enzymes were significantly (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBerberineBerberisLyciumNeuroprotective AgentsRatsAnimalsAluminum ChlorideMolecular Docking SimulationRivastigmineAcetylcholinesteraseAmyloid Precursor Protein SecretasesDopamineMethanolSerotoninAcetates

Substanzen

BerberineAluminum ChlorideRivastigmineAcetylcholinesteraseAmyloid Precursor Protein SecretasesDopamineMethanolSerotoninNeuroprotective Agentsethyl acetate

Autor:innen und Institutionen

  • Department of Biochemistry and Biotechnology, University of Gujrat, Gujrat, Pakistan.
  • Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • Department of Zoology, Wildlife and Fisheries, University of Agriculture, Faisalabad, Pakistan.
  • Department of Bioinformatics and Biosciences, Faculty of Health and Life Sciences, Capital University of Science and Technology, Islamabad, Pakistan.
  • Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
  • Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.

ORCID-Profile: Hammad Ismail, Muhammad Umar Ijaz

Förderung

  • Committee on Scientific and Technological Cooperation of the Organization of Islamic Conference, Islamabad, Pakistan and International Foundation for Science

Zitieren

APA

Ismail, H., Khalid, D., Waseem, D., Ijaz, M. U., Dilshad, E., Haq, I. U., Bhatti, M. Z., Anwaar, S., Ahmed, M., & Saleem, S. (2023). RETRACTED: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer’s disease combined with insilico molecular docking. PLOS ONE. https://doi.org/10.1371/journal.pone.0286349

Vancouver

Ismail H, Khalid D, Waseem D, Ijaz MU, Dilshad E, Haq IU, et al. RETRACTED: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer’s disease combined with insilico molecular docking. PLOS ONE. 2023. doi:10.1371/journal.pone.0286349

BibTeX
@article{Ismail2023,
  author = {Ismail, Hammad and Khalid, Dania and Waseem, Durdana and Ijaz, Muhammad Umar and Dilshad, Erum and Haq, Ihsan-Ul and Bhatti, Muhammad Zeeshan and Anwaar, Sadaf and Ahmed, Madiha and Saleem, Samreen},
  title = {RETRACTED: Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer’s disease combined with insilico molecular docking},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286349}
}
Kostenlos starten →